Skip to content

Prognostic analysis of long-term survival in patients with advanced non-small cell lung cancer in Henan Province

Prognostic analysis of long-term survival in patients with advanced non-small cell lung cancer in Henan Province

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037819
Enrollment
Unknown
Registered
2020-09-02
Start date
2020-10-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Gold Standard:Clinical outcome
Index test:Long-term survival model for patients with advanced non-small cell lung cancer in Henan Province

Sponsors

Zhengzhou Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The diagnosis of primary lung cancer was clear; (2) the types of lung cancer were confirmed by histopathology or cytology: squamous cell carcinoma, adenocarcinoma, large cell carcinoma and undifferentiated cancer; (3) no anti-tumor treatment was conducted in the past; (4) no history of other malignant tumors; (5) body mass index was based on the value at admission (BMI = weight / height 2) )According to the WHO Asian classification criteria, low body weight group (BMI = 28.00kg / m2); (6) smoking index = number of cigarettes per day x years of smoking, smoking index > 400 was defined as high-risk population of lung cancer, = 70 points; (10) the possible drug-related side effects during the treatment were informed and informed consent was signed; (11) the patient's medical records and follow-up data were complete.

Exclusion criteria

Exclusion criteria: (1) pregnant and lactating women, or recent family planning; (2) patients with severe heart failure, respiratory failure, renal dysfunction and other important organ dysfunction; (3) patients with previous or existing mental symptoms.

Design outcomes

Primary

MeasureTime frame
OS;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactKong Tiandong

Zhengzhou Third People's Hospital

kongtiandong@126.com+86 371-66992915

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026